How Patient-Derived Stem Cells are Changing the Trajectory of Congenital Heart Disease Research
How Patient-Derived Stem Cells are Changing the Trajectory of Congenital Heart Disease Research https://pediatricsnationwide.org/wp-content/uploads/2021/10/iStock_000014186415XLarge-1024x683.jpg 1024 683 Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gifSmall blood samples — and the patient-specific, induced pluripotent stem cells (iPSCs) they enable — turn into valuable research material for understanding congenital cardiovascular disorders, especially when united with modern genome sequencing and editing, animal models and three dimensional tissue growth technologies. Patient-derived induced pluripotent stem cells (iPSCs) have a significant downside for studying most…
read more